QQ客服 官方微博 反馈留言

	Are phosphodiesterase type 5 inhibitors associated with increased risk of melanoma?
	Shijian Feng; Liang Zhou; Qinyu Liu; Qing He; Banghua Liao; Xin Wei; Hong Li; Kunjie Wang; Yuchun Zhu
刊名	Medicine (Baltimore)
	2018
卷号	Vol.97 No.3页码:e9601
关键词	melanoma phosphodiesterase type 5 inhibitor risk factor systematic review
ISSN号	0025-7974
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1841835
专题	四川大学
作者单位	Sichuan Univ, West China Hosp, Lab Reconstruct Urol, Dept Urol,Inst Urol, Chengdu, Sichuan, Peoples R China
推荐引用方式 GB/T 7714	Shijian Feng,Liang Zhou,Qinyu Liu,et al. Are phosphodiesterase type 5 inhibitors associated with increased risk of melanoma?[J]. Medicine (Baltimore),2018,Vol.97 No.3:e9601.
APA	Shijian Feng.,Liang Zhou.,Qinyu Liu.,Qing He.,Banghua Liao.,...&Yuchun Zhu.(2018).Are phosphodiesterase type 5 inhibitors associated with increased risk of melanoma?.Medicine (Baltimore),Vol.97 No.3,e9601.
MLA	Shijian Feng,et al."Are phosphodiesterase type 5 inhibitors associated with increased risk of melanoma?".Medicine (Baltimore) Vol.97 No.3(2018):e9601.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。